Abstract: Embodiments of the present disclosure disclose an audio processing method, applied to a cloud interactive system, where the cloud interactive system includes user equipment and a server. The method includes detecting, by a server device that interacts with user equipment in an interactive system, a calling to an audio interface from an interactive application, generating according to a type of the audio interface, an audio instruction corresponding to the type when the calling is detected determining whether a record that audio data corresponding to the audio instruction is sent to user equipment in the interactive system exists, and sending, by the server device, the audio instruction to the user equipment when the record exists. In response to the audio instruction, the user equipment executes the audio instruction using cached audio data.

Abstract: A graphical instruction data processing method and apparatus, and a system are disclosed, to help reduce a quantity of transmitted graphical instruction data, and lower a requirement on bandwidth. Aspects of the disclosure provide a method for processing graphical instruction data. The method includes obtaining, by a server device in a cloud interactive system, graphical instruction data of a frame, and determining whether the frame satisfies a key frame setting condition. Further, the method includes when the frame is determined to fail to satisfy the key frame setting condition, comparing the graphical instruction data of the frame with graphical instruction data of a current key frame, to obtain differential data, and sending the differential data to user equipment in the cloud interactive system. The user equipment reconstructs the graphical instruction data of the frame according to the current key frame and the differential data.

Abstract: A compound of Formula I or pharmaceutically acceptable salt thereof and its preparation method and applications, the new structure of the compound of formula I has not been reported in literature. It is isolated from Isodon forrestii var. forrestii and can be a compound served as Trx1 selective inhibitor. The present invention further discloses a pharmaceutical composition, preparation of the compound of Formula I and its applications in preparing medicines for preventing or treating cancer. Iso A of the present invention has the advantages of low toxicity, high safety and strong pharmacological effect, which suggests a potential prospect in pharmaceutical applications.

Abstract: A compound of Formula I or pharmaceutically acceptable salt thereof and its preparation method and applications, the new structure of the compound of formula I has not been reported in literature. It is isolated from Isodon forrestii var. forrestii and can be a compound served as Trx1 selective inhibitor. The present invention further discloses a pharmaceutical composition, preparation of the compound of Formula I and its applications in preparing medicines for preventing or treating cancer. Iso A of the present invention has the advantages of low toxicity, high safety and strong pharmacological effect, which suggests a potential prospect in pharmaceutical applications.

Abstract: A disulfiram formulation comprising disulfiram or a derivative thereof together with a component that increases the in vivo half life of the disulfiram or the derivative thereof, and methods and uses thereof. In particular, the disulfiram formulation is used with or without a separate copper formulation for the treatment of cancer.